BACKGROUND: Women have approximately twice the risk of major depressive disorder (MDD) than men, yet this difference remains largely unexplained. Previous MDD research suggests high rates of endocrine dysfunction, which may be related to deficits in brain activity in stress response circuitry [hypothalamus, amygdala, hippocampus, anterior cingulate cortex (ACC), orbitofrontal cortex (OFC)]. This functional magnetic resonance imaging (fMRI) study investigated the relationship between hypothalamic-pituitary-gonadal (HPG)-axis hormones and stress response circuitry dysfunction in MDD in women. METHODS: During the late follicular/midcycle phase of the menstrual cycle, female participants (10 with extensive histories of MDD, in remission, 10 healthy controls) were scanned while viewing negative and neutral arousal pictures. Group differences in blood oxygen-level dependent (BOLD) signal changes were analyzed using SPM2. Baseline gonadal hormones included estradiol, progesterone, and testosterone. RESULTS: fMRI results showed greater BOLD signal intensity changes in controls versus MDD in hypothalamus, amygdala, hippocampus, OFC, ACC, and subgenual ACC, findings unrelated to medication status. MDD women had a lower serum estradiol and higher serum progesterone compared to controls. Hypoactivations in hypothalamus, subgenual ACC, amygdala and OFC in MDD were associated with low estradiol and high progesterone. LIMITATIONS: Generalizability of our findings is limited by small sample size and restriction to females, although this did not affect the internal validity of the results. CONCLUSIONS: Hypoactivation of the stress response circuitry in MDD women is associated with dysregulation of the HPG-axis. Associations between brain activity deficits and hormonal disruption in MDD may ultimately contribute to understanding sex differences in MDD.
BACKGROUND:Women have approximately twice the risk of major depressive disorder (MDD) than men, yet this difference remains largely unexplained. Previous MDD research suggests high rates of endocrine dysfunction, which may be related to deficits in brain activity in stress response circuitry [hypothalamus, amygdala, hippocampus, anterior cingulate cortex (ACC), orbitofrontal cortex (OFC)]. This functional magnetic resonance imaging (fMRI) study investigated the relationship between hypothalamic-pituitary-gonadal (HPG)-axis hormones and stress response circuitry dysfunction in MDD in women. METHODS: During the late follicular/midcycle phase of the menstrual cycle, female participants (10 with extensive histories of MDD, in remission, 10 healthy controls) were scanned while viewing negative and neutral arousal pictures. Group differences in blood oxygen-level dependent (BOLD) signal changes were analyzed using SPM2. Baseline gonadal hormones included estradiol, progesterone, and testosterone. RESULTS: fMRI results showed greater BOLD signal intensity changes in controls versus MDD in hypothalamus, amygdala, hippocampus, OFC, ACC, and subgenual ACC, findings unrelated to medication status. MDDwomen had a lower serum estradiol and higher serum progesterone compared to controls. Hypoactivations in hypothalamus, subgenual ACC, amygdala and OFC in MDD were associated with low estradiol and high progesterone. LIMITATIONS: Generalizability of our findings is limited by small sample size and restriction to females, although this did not affect the internal validity of the results. CONCLUSIONS: Hypoactivation of the stress response circuitry in MDDwomen is associated with dysregulation of the HPG-axis. Associations between brain activity deficits and hormonal disruption in MDD may ultimately contribute to understanding sex differences in MDD.
Authors: C Fahim; E Stip; A Mancini-Marie; B Mensour; J-M Leroux; G Beaudoin; P Bourgouin; M Beauregard Journal: Brain Cogn Date: 2004-03 Impact factor: 2.310
Authors: Jill M Hooley; Staci A Gruber; Laurie A Scott; Jordan B Hiller; Deborah A Yurgelun-Todd Journal: Biol Psychiatry Date: 2005-04-01 Impact factor: 13.382
Authors: M Beauregard; J M Leroux; S Bergman; Y Arzoumanian; G Beaudoin; P Bourgouin; E Stip Journal: Neuroreport Date: 1998-10-05 Impact factor: 1.837
Authors: William Irwin; Michael J Anderle; Heather C Abercrombie; Stacey M Schaefer; Ned H Kalin; Richard J Davidson Journal: Neuroimage Date: 2004-02 Impact factor: 6.556
Authors: Simon Surguladze; Michael J Brammer; Paul Keedwell; Vincent Giampietro; Andrew W Young; Michael J Travis; Steven C R Williams; Mary L Phillips Journal: Biol Psychiatry Date: 2005-02-01 Impact factor: 13.382
Authors: Tal Shafir; Tiffany Love; Alison Berent-Spillson; Carol C Persad; Heng Wang; Nancy K Reame; Kirk A Frey; Jon-Kar Zubieta; Yolanda R Smith Journal: Behav Brain Res Date: 2011-09-14 Impact factor: 3.332
Authors: Mary L Phillips; Henry W Chase; Yvette I Sheline; Amit Etkin; Jorge R C Almeida; Thilo Deckersbach; Madhukar H Trivedi Journal: Am J Psychiatry Date: 2015-02-01 Impact factor: 18.112
Authors: Michael J Crowley; Jia Wu; Rebecca E Hommer; Mikle South; Peter J Molfese; R M P Fearon; Linda C Mayes Journal: Dev Neuropsychol Date: 2013 Impact factor: 2.253
Authors: Jill M Goldstein; Katie Lancaster; Julia M Longenecker; Brandon Abbs; Laura M Holsen; Sara Cherkerzian; Susan Whitfield-Gabrieli; Nicolas Makris; Ming T Tsuang; Stephen L Buka; Larry J Seidman; Anne Klibanski Journal: Psychiatry Res Date: 2015-03-31 Impact factor: 3.222
Authors: Roee Admon; Laura M Holsen; Harlyn Aizley; Anne Remington; Susan Whitfield-Gabrieli; Jill M Goldstein; Diego A Pizzagalli Journal: Biol Psychiatry Date: 2014-10-02 Impact factor: 13.382
Authors: Kristina M Deligiannidis; Elif M Sikoglu; Scott A Shaffer; Blaise Frederick; Abby E Svenson; Andre Kopoyan; Chelsea A Kosma; Anthony J Rothschild; Constance M Moore Journal: J Psychiatr Res Date: 2013-03-15 Impact factor: 4.791
Authors: Nikos Makris; Dick F Swaab; Andre van der Kouwe; Brandon Abbs; Denise Boriel; Robert J Handa; Stuart Tobet; Jill M Goldstein Journal: Neuroimage Date: 2012-12-14 Impact factor: 6.556